0420B |
Betahydroxybutyric Acid, Blood |
0420FL |
Betahydroxybutyric Acid, Fluid |
0560P |
Benzocaine, Plasma |
0560U |
Benzocaine, Urine |
0568B |
Benzodiazepines Screen, Blood |
0568FL |
Benzodiazepines Screen, Fluid |
0568SP |
Benzodiazepines Screen, Serum/Plasma |
0568U |
Benzodiazepines Screen, Urine |
0642SP |
Betahydroxybutyric Acid, Serum/Plasma |
0642U |
Betahydroxybutyric Acid, Urine |
0800B |
Bupivacaine, Blood |
0800FL |
Bupivacaine, Fluid |
0800SP |
Bupivacaine, Serum/Plasma |
0800U |
Bupivacaine, Urine |
6922H |
Benzodiazepines Screen, Hair |
8891OF |
Benzodiazepines Panel (Qualitative), Oral Fluid (Saliva) |
9329B |
Benzodiazepines Panel, Blood |
9329FL |
Benzodiazepines Panel, Fluid |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9329TI |
Benzodiazepines Panel, Tissue |
9329U |
Benzodiazepines Panel, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |